Disease Control Among Patients With Diabetes and Severe Depressive Symptoms

Journal of Primary Care & Community Health
Amy WerremeyerNatasha Petry

Abstract

Major depressive disorder and type 2 diabetes commonly co-occur and disease control tends to be poorer when both conditions are present. However, little research has examined the disease characteristics of patients with diabetes and more severe depressive symptoms. We report a retrospective observational study of 517 patients with diabetes from 2 primary care centers. Patients with diabetes and moderately-severe/severe depression symptoms (Patient Health Questionnaire [PHQ-9] score >15) were compared with patients with diabetes without moderate or severe depression symptoms (PHQ-9 score <15; the comparison group) with regard to control of diabetes, blood pressure, and lipid parameters. Frequency of HbA1c and PHQ-9 testing were also examined. Patients with diabetes and moderately severe/severe depressive symptoms had higher HbA1c (7.56% vs. 7.09%), diastolic blood pressure (78.43 vs. 75.67 mm Hg), and low-density lipoprotein cholesterol (109.12 vs. 94.22 mg/dL) versus the comparison group. Patients with diabetes and moderately-severe/severe depression underwent HbA1c and PHQ-9 testing with similar frequency to the comparison group. The presence of moderately severe/severe depressive symptoms was associated with poorer glucose, l...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Aug 4, 2001·Psychosomatic Medicine·M de GrootP J Lustman
Oct 16, 2002·Journal of Psychosomatic Research·Susan A EversonGeorge A Kaplan
Mar 23, 2005·American Journal of Epidemiology·Xuanping ZhangHenry S Kahn
Jul 8, 2005·The New England Journal of Medicine·Sotirios TsimikasPeter B Berger
Oct 24, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·J W Stephens, R Williams
Jun 19, 2008·JAMA : the Journal of the American Medical Association·Sherita Hill GoldenConstantine Lyketsos
Jul 24, 2008·Journal of General Internal Medicine·Wayne KatonMichael Schoenbaum
Nov 27, 2008·Diabetes Care·Jeffrey S GonzalezSteven A Safren
Apr 28, 2012·Circulation·Sarah ParishUNKNOWN Heart Protection Study Collaborative Group
May 23, 2012·Diabetes Care·Deborah J WexlerRichard W Grant
Feb 19, 2013·General Hospital Psychiatry·Mijung ParkFredric M Wolf
Nov 7, 2013·Nephron. Clinical Practice·Margaret K YuBessie A Young
Jan 7, 2014·Journal of Primary Care & Community Health·James E Rohrer
Dec 30, 2014·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Jan 27, 2017·Primary Care Diabetes·Tomoyuki Kawada
Aug 26, 2016·The Diabetes Educator·Mykell BarnacleNatasha Petry
Feb 20, 2021·International Journal of General Medicine·Zhaoqi Jia, Sen Li

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.